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Rett Syndrome (RTT) is an autism spectrum disorder
caused by mutations in the X-linked gene encoding
methyl-CpG binding protein 2 (MeCP2). In order to
map the neuroanatomic origins of the complex neu-
ropsychiatric behaviors observed in patients with
RTT and to uncover endogenous functions of
MeCP2 in the hypothalamus, we removed Mecp2
from Sim1-expressing neurons in the hypothalamus
using Cre-loxP technology. Loss of MeCP2 in Sim1-
expressing neurons resulted in mice that recapitu-
lated the abnormal physiological stress response
that is seen upon MeCP2 dysfunction in the entire
brain. Surprisingly, we also uncovered a role for
MeCP2 in the regulation of social and feeding behav-
iors since the Mecp2 conditional knockout (CKO)
mice were aggressive, hyperphagic, and obese.
This study demonstrates that deletingMecp2 in a de-
fined brain region is an excellent approach to map
the neuronal origins of complex behaviors and pro-
vides new insight about the function of MeCP2 in
specific neurons.
INTRODUCTION
Rett Syndrome (RTT) is a devastating X-linked neurodevelop-
mental disorder that affects 1 in 10,000 females (Moretti and
Zoghbi, 2006). Patients with classic RTT suffer from a broad ar-
ray of phenotypes that affect almost every part of the central and
autonomic nervous systems (Glaze, 2005; Weaving et al., 2005).
These phenotypes include impaired social behavior and com-
munication skills, motor abnormalities, and the development of
stereotyped movements (Hagberg, 2002).
The majority (>95%) of RTT cases are caused by mutations in
the gene encoding methyl-CpG-binding protein 2 (MeCP2),
a protein widely expressed throughout the brain (Williamsonand Christodoulou, 2006; Zoghbi, 2005). In addition to classic
RTT, patients withMECP2mutationsmanifest a variety of neuro-
psychiatric conditions, including autism, juvenile onset schizo-
phrenia, and bipolar disease, with mental retardation depending
on the type of mutation or the pattern of X chromosome inactiva-
tion (XCI) (Cohen et al., 2002;Weaving et al., 2003). Girls typically
have features of classic RTT when they have random XCI,
whereby half of their cells express a mutantMECP2 allele (Shah-
bazian et al., 2002b; Takagi, 2001). In contrast, patients with
skewed patterns of XCI favoring the wild-type (WT) allele might
display only a few features, such as autism, tremor, or other neu-
robehavioral deficits. Because the majority of cells in girls with
favorable XCI patterns express theWT allele, the isolated pheno-
typesmight result from loss of MeCP2 function in particular brain
regions.
The creation of several mouse models carrying different
Mecp2mutations enabled the recapitulation of many of the phe-
notypes seen in patients and has enhanced our appreciation of
the breadth of clinical phenotypes that are associated with
RTT. Mecp2 null mice display tremor, breathing dysfunction,
and hind-limb clasping; are overweight (on a mixed 129,
C57BL/6, BALB/c genetic background); and die by 10 weeks
(Chen et al., 2001; Guy et al., 2001). Mice bearing a truncated
Mecp2 allele (Mecp2308/Y) are overweight (on a 129 Sv/Ev back-
ground, unpublished data); display motor dysfunction, seizures,
stereotypies, altered social behavior, abnormal stress re-
sponses, and anxiety-like behavior; and die by 15 months of
age (McGill et al., 2006; Moretti et al., 2005; Shahbazian et al.,
2002a). Conditional deletion of Mecp2 from neurons that ex-
press CaMKII-Cre93 throughout the forebrain and midbrain re-
produces a large subset of RTT features, including abnormal
motor coordination, anxiety-like behavior, impaired learning
and memory, and weight gain (Gemelli et al., 2006). The over-
weight phenotype seen in each of the mousemodels was initially
perplexing given that girls with classic RTT are typically thin and
often suffer from growth failure predominantly because of feed-
ing difficulties due to oropharyngeal dysmotility (difficulty chew-
ing and swallowing) (Motil et al., 1999). However, upon reflection
on the clinical course of many patients with MECP2 mutationsNeuron 59, 947–958, September 25, 2008 ª2008 Elsevier Inc. 947
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pomorphic MECP2 mutations and females with milder variants
of RTT often become obese (Couvert et al., 2001; Kleefstra
et al., 2002; Zappella et al., 2001).
Studying patients with RTT, as well as mouse models of RTT,
is a daunting task given the incredible range of phenotypes that
stem fromMeCP2 dysfunction in all neurons. Moreover, it is very
difficult to dissociate phenotypes attributable to dysfunction of
MeCP2 from secondary compensatory changes. Given the clin-
ical observation that different patterns of XCI likely result in the
manifestation of distinct subsets of RTT phenotypes, we pro-
posed that particular RTT phenotypes result from loss of function
of MeCP2 in specific neurons and that deleting Mecp2 from
small groups of neurons in the mouse will enable us to map spe-
cific neurobehavioral phenotypes to discrete brain regions or cell
types. Furthermore, we reasoned that this strategy should allow
us to uncover endogenous functions of MeCP2 that might other-
wise be masked in the constitutiveMecp2 null mice that display
many phenotypes.
In this work, we focus on the hypothalamus because patients
with MECP2 mutations display many phenotypes suggestive of
hypothalamic dysfunction, such as sleep abnormalities, epi-
sodes of heightened anxiety, an abnormal physiological re-
sponse to stress as measured by increased levels of cortisol in
the urine, gastrointestinal dysfunction, as well as cardiac and
breathing abnormalities (Axelrod et al., 2006; Motil et al., 1999,
2006; Mount et al., 2002; Young et al., 2007). In this study, we uti-
lized mice that express Cre recombinase under the control of
Sim1 regulatory elements to delete Mecp2 in several regions of
the hypothalamus using Cre-loxP technology. We performed
a comprehensive battery of behavioral and physiological tests
on Mecp2 conditional knockout (CKO) mice and all littermate
controls to screen for the presence of both RTT-like and distinct
phenotypes, and we discovered that MeCP2 plays a critical role
in pathways important for mediating proper physiological re-
sponses to stress as well as both social and feeding behaviors.
RESULTS
Selective Deletion ofMecp2 in Sim1-Expressing
Neurons
We removedMecp2 from Sim1-expressing neurons by breeding
mice carrying a Mecp2 allele flanked by loxP sites (Mecp2flox/+)
(Guy et al., 2001) to Sim1-cre BAC transgenic mice (Balthasar
et al., 2005). Sim1 regulatory elements drive Cre expression in
transgenic mice during embryonic development and after birth
in the paraventricular (PVN), supraoptic (SON), and posterior
(PH) hypothalamic nuclei, as well as in the nucleus of the lateral
olfactory tract (NLOT) of the amygdala (Balthasar et al., 2005). A
small amount of scattered Cre expression also occurs in a few
other areas surrounding the hypothalamus and amygdala (Balth-
asar et al., 2005); however, this is very minimal compared to the
robust Cre expression found in the nuclei mentioned above.
Fluorescent immunohistochemistry demonstrated a clear reduc-
tion of MeCP2 in all areas where Cre is expressed, including the
PVN (Figures 1A and 1B) and SON (Figures 1C and 1D) ofMecp2
conditional knockout (Mecp2CKO)mice. MeCP2 levels were not948 Neuron 59, 947–958, September 25, 2008 ª2008 Elsevier Inc.altered in the suprachiasmatic nucleus (SCN), an area of the
hypothalamus where the Cre is not expressed (data not shown).
Mecp2 CKO Mice Display an Increased Physiological
Response to Stress
To screen for the presence of RTT-like phenotypes, we per-
formed a comprehensive battery of behavioral tests on Mecp2
CKO mice and all littermate controls (Table 1). Although Mecp2
CKO mice behaved similarly to their littermates in a variety of
paradigms (Figure S1 available online), they also reproduced
a subset of phenotypes typically detected with MeCP2 dysfunc-
tion throughout the brain (Table 1). In light of the increased uri-
nary cortisol excretion in patients with RTT (Motil et al., 2006)
and the higher serum corticosterone in Mecp2308/Y mice after
stress (McGill et al., 2006), we examined endocrine responses
to stress inMecp2CKOmice. Wemeasured serum levels of cor-
ticosterone in Mecp2 CKO and control mice under basal condi-
tions and after 30 min of restraint stress. We found a significant
effect of genotype under basal conditions, F(3,28) = 5.28, p =
0.005, and after stress, F(3,27) = 8.70, p < 0.001. Tukey’s post
hoc comparisons revealed that, under basal conditions,
Mecp2flox and Mecp2 CKO mice had similar corticosterone
levels compared to WT mice, although their levels were higher
than mice that carry only the Sim1-cre transgene (p < 0.05 for
both, Figure 2A). Strikingly, after 30 min of restraint, Mecp2
CKO mice had significantly higher corticosterone levels than all
littermate controls, and they exhibited a 134% increase in serum
corticosterone over WT littermates (p < 0.01, Figure 2A). These
results indicate that, similar to patients with RTT and
Mecp2308/Y mice, Mecp2 CKO mice have an enhanced physio-
logic response to stress.
We next attempted to determine whether Mecp2 CKO mice
also exhibit increased anxiety-like behavior. In the open field,
there was a significant effect of genotype for the center-to-total
distance ratio, F(3,60) = 7.58, p < 0.001 (Figure 2B). Tukey’s post
hoc comparison revealed that Mecp2 CKO mice explored the
center of an open field significantly less than all controls, a finding
consistent with enhanced anxiety-like behavior. The total dis-
tance traveled in the open field was similar among Mecp2 CKO
and WT mice, indicating that the decreased exploration of the
center of the arena byMecp2 CKO mice was not likely the result
of motor impairment (Figure 2C). It should be noted, however,
that we did observe a small but significant decrease in the total
distance that the Mecp2 CKO mice traveled throughout the
test when compared to mice that carry only the Sim1-cre allele
(p < 0.01). To confirm that the Mecp2 CKO mice display in-
creased anxiety-like behavior, we performed a light-dark box
assay, one of the most widely used and well-documented tests
for studying anxiety-like behavior (Bourin and Hascoet, 2003).
Analysis of the data by two-way analysis of variance (ANOVA)
demonstrated a significant effect of genotype (Mecp2flox 3
Sim1-cre interaction) on both the percentage of time spent in
the lit side, F(1,60) = 4.08, p = 0.048, and the number of transi-
tions between compartments, F(1,60) = 5.85, p = 0.019. Interest-
ingly, however, one-way ANOVA with Tukey’s post hoc analysis
revealed thatMecp2 CKOmice spent a similar amount of time in
the lit side of the light-dark box compared to all littermate con-
trols (Figure 2D). Furthermore, the number of transitions between
Neuron
MeCP2 Plays a Critical Role in Sim1 NeuronsFigure 1. Mecp2 CKO Mice Display a Decreased Amount of MeCP2 in the Paraventricular Nucleus and the Supraoptic Nucleus of the
Hypothalamus Compared to Littermate Controls
Detection of MeCP2 (red) by immunofluorescence in the paraventricular nucleus (PVN) of mice carrying only the Sim1-cre transgene (A) andMecp2CKOmice (B)
and in the supraoptic nucleus (SON) of mice carrying only the Mecp2flox allele (C) and Mecp2 CKO mice (D). TOTO-3 staining in blue marks cell nuclei.
Scale bar, 100 mm (A and B); 62.5 mm (C and D).compartments and the latency to enter the dark were not differ-
ent between Mecp2 CKO mice and WT controls (data not
shown). Thus, although Mecp2 CKO mice clearly display an
increased physiological response to stress and a decreased
center-to-total distance ratio in the open field assay, the light-
dark data do not reveal increased anxiety-like behavior in the
Mecp2 CKO mice.
Mecp2 CKO Mice Exhibit Abnormal Social Behavior
in the Form of Increased Aggression
Mecp2 CKO mice also behaved abnormally in the partition test,
which is designed to evaluate social behavior. In this test, two
mice are placed in a cage divided by a clear and perforated plex-
iglass partition, and the amount of time that the test mouse
spends near the partition investigating either a familiar or an un-
familiar partner is recorded. Repeated-measures ANOVA (geno-
type 3 time) revealed a significant effect, F(3,59) = 10.65, p <
0.001, and Tukey’s post hoc analysis demonstrated that
Mecp2 CKO mice (p < 0.001) and mice that carry only the
Mecp2flox allele (p < 0.05) spent more time at the partition com-
pared to control littermates, suggesting increased social interac-
tion (Figure 2E). This Mecp2flox effect is consistent with data
reported in a recent study (Samaco et al., 2008). This study dem-
onstrated that mice carrying the Mecp2flox allele express 50%
less MeCP2 compared toWT littermates, highlighting the impor-
tance of including Mecp2flox mice as controls when interpretingdata from Mecp2 CKO experiments. Interestingly, we noticed
that Mecp2 CKO and Mecp2flox mice engaged in very different
behaviors at the partition. Mice that carry only the Mecp2flox
allele demonstrated typical social interactions, such as sniffing
and exploration. In contrast, Mecp2 CKO mice were preoccu-
pied with aggressive behaviors, such as tail rattling directed
toward the unfamiliar partner.
To further characterize these aggressive behaviors, we used
the resident intruder assay. Prior to testing the response of a res-
ident mouse to an intruder, the test mice were singly housed for
2 weeks, a procedure believed to enhance territoriality. On the
test day, we recorded aggressive behaviors after placing
a smaller, unfamiliar, group-housed WT mouse into the home
cage of the test mouse. Scores used to denote aggressive be-
haviors included the number of attacks, mounting, biting, and
tail rattling events. Mecp2 CKO mice engaged in significantly
more tail rattles (p < 0.01) and aggressive attacks (p < 0.01)
than their control littermates (Figure 2F and Movies S1 and
S2). In fact, out of the 24 control littermates tested, not a single
tail rattle or attack was recorded during the test period. Notably,
the aggression observed inMecp2 CKOmice appears to be lim-
ited to situations when they are stressed, either as a result of
being singly housed or as a specific reaction to novel intruders
of their territory, since they do not attack their familiar cage
mates. Furthermore, they are not aggressive toward the exam-
iner when they are handled.Neuron 59, 947–958, September 25, 2008 ª2008 Elsevier Inc. 949
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Fat Mass, and Body Length
Mecp2 CKO mice fed regular mouse chow ad libitum exhibited
significantly increased body weight after 7 weeks of age (re-
peated-measures two-way ANOVA [Mecp2flox 3 Sim1-cre],
lower-bound F(1,60) = 19.59, p < 0.001, Tukey’s post hoc p <
0.01; Figures 3A and 3B). Mecp2 CKO mice weigh 27% more
than their control littermates by 18 weeks and 48% more by
42 weeks (Figures 3B and S2). We examined linear growth and
found thatMecp2 CKO mice also exhibit a small (3%) but signif-
icant (p < 0.05) increase in body length compared to littermate
controls at 42 weeks of age (data not shown).
To determine whether the observed weight gain was due to
increased adiposity, we dissected and weighed intra-abdomi-
nal gonadal fat pads. We found a significant effect of genotype,
F(3,28) = 8.91, p < 0.001, and Tukey’s post hoc comparison re-
vealed that gonadal fat pad masses were greatly increased in
the Mecp2 CKO mice compared to all controls (p < 0.01,
Figure 3C), suggesting that their increased body weight is pri-
marily due to an increase in body fat deposition. In order to
confirm these findings, we performed dual energy X-ray ab-
sorptiometry (DEXA) scans on Mecp2 CKO mice to determine
body composition. DEXA analysis indicated that Mecp2 CKO
mice had increased total body fat percentages (36% ± 3%)
compared to control littermates (20% ± 1%) at 20 weeks of
age (p < 0.05, Figure 3D). These data demonstrate that the in-
creased body weight in Mecp2 CKO mice is primarily due to
increased body fat.
Mecp2 CKO Mice Display Normal Activity and Basal
Metabolic Rates but Are Hyperphagic
To probe the cause of obesity in theMecp2 CKO mice, we used
an automated home cage monitoring system to evaluate daily
activity and food intake. Average daily total movement values
were not significantly different between Mecp2 CKO mice and
control littermates, although a trend toward hypoactivity (p =
0.066) was noted in the Mecp2 CKO mice (Figure 4A). Interest-
Table 1. A Summary of the Behavioral Assays and Their Outcome
in Mecp2 CKO Mice
Behavior Assay Phenotype Tested
Phenotype Observed
in Mecp2 CKO
General health exam Body weight,
stereotypies, kyphosis
Yes
Wire hang and dowel Motor coordination No
Tremor monitoring Tremor No
Light-dark box Anxiety-like behavior No
Open field Anxiety-like behavior Yes
Conditioned fear Learning and memory No
Partition test Social behavior Yes
Resident intruder Aggression Yes
Aging of animals Reduced survival No
Acomprehensivebatteryofbehavioral assayswasperformedonF1129/FVB
maleMecp2CKOmice and their control littermates (n = 15–17/genotype)
to assess whether any RTT-like features were recapitulated after deleting
Mecp2 from Sim1-expressing neurons.950 Neuron 59, 947–958, September 25, 2008 ª2008 Elsevier Inc.ingly, on experimental day 1, Mecp2 CKO mice completely
lacked the novelty-induced hyperactivity response that is nor-
mally seen in WT mice (Figure 4A), likely due to heightened
anxiety. We evaluated oxygen consumption using indirect calo-
rimetry and found thatMecp2CKOmice have normal basal met-
abolic rates (Figure 4B). Together, these data suggest that the
marked obesity observed in theMecp2CKOmice is not second-
ary to a decrease in energy expenditure. We next evaluated en-
ergy consumption by monitoring daily food intake. After a 4 day
acclimation period,weanalyzed food consumption over a subse-
quent 4 day period. We found a significant effect of genotype,
F(3,26) = 13.17, p < 0.001, and Tukey’s post hoc comparison
revealed that Mecp2 CKO mice are hyperphagic, consuming,
on average, 42% more chow than WT controls (p < 0.001,
Figure 4C). Interestingly, Mecp2 CKO mice did not consume
extra chow compared to WT mice throughout the 24 hr period
(experimental day 1) immediately after they were singly housed
in novel cages, suggesting that they experienced stress-induced
suppression of food intake during that period (Figure 4C).
Mecp2 CKO Mice Have High Serum Levels of Leptin
Feeding behavior is regulated by several signaling molecules
and hormones (for a recent review, see Oswal and Yeo, 2007).
One major signal that the body uses to sense energy balance
is leptin, a soluble hormone secreted by adipocytes to commu-
nicate body fat deposition information to the brain. To investigate
possiblemechanisms responsible formediating the hyperphagia
in Mecp2 CKO mice, we measured serum leptin levels. We did
not detect any significant difference in serum leptin at 6 weeks
of age, but, by 42 weeks, we found a significant effect of geno-
type, F(2,17) = 31.48, p < 0.001, and Tukey’s post hoc compar-
ison revealed that Mecp2 CKO mice had a 4-fold increase (p <
0.001) in leptin compared to WT controls (Figure 4D). The obser-
vation thatMecp2CKOmice are obese in the context of elevated
leptin suggests that they are able to produce and secrete leptin
but are insensitive to its effects. Furthermore, because leptin
levels are normal at 6 weeks, prior to the onset of obesity, we
conclude that the increased leptin levels likely result from in-
creased fat deposition in the older mice and are not due to direct
leptin regulation by MeCP2.
Mecp2 CKO Mice Express High Levels of Npy
in the Dorsomedial Nucleus of the Hypothalamus (DMH)
Since the melanocortin pathway is an important mediator of lep-
tin signaling in the hypothalamus (Oswal and Yeo, 2007), we next
evaluated the expression of several members of this pathway, in-
cluding the melanocortin 4 receptor (Mc4r), pro-opiomelanocor-
tin (Pomc1), agouti-related protein (Agrp), and neuropeptide Y
(Npy), by in situ hybridization inMecp2 CKOmice and control lit-
termates. POMC and AgRP/NPY neurons in the arcuate nucleus
(ARC) are activated and repressed by leptin, respectively, and
they project to the PVN where POMC neurons stimulate and
AgRP/NPY neurons block the activity of MC4Rs (Haskell-
Luevano and Monck, 2001; Schwartz et al., 1997). Proper
MC4R signaling in the PVN is critical for the regulation of food in-
take (Balthasar et al., 2005). RNA in situ hybridization revealed
that expression of Mc4r in the PVN (Figures 5A and 5B) and
Pomc1 (Figures 5C and 5D) and Agrp in the ARC (Figures 5E
Neuron
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Neurons Results in an Abnormal Stress Response,
Decreased Movement in the Center of an Open
Field Arena, and Aggressive Behaviors
(A) Serum corticosterone measurement by enzyme-linked
immunosorbent assay (ELISA) before and after 30 min of
stress in Mecp2 CKO mice and control littermates (n =
7–9/genotype). Under basal conditions, WT;Mecp2flox
and Mecp2 CKO mice had higher serum corticosterone
levels compared to Sim1-cre;WT mice; however, there
was no significant difference between WT and Mecp2
CKOmice. After stress,Mecp2CKOmice had significantly
higher serum corticosterone levels compared to all
littermates.
(B) Open field analysis revealed thatMecp2CKOmice had
a lower center-to-total distance ratio compared to all litter-
mate controls.
(C) The total distance traveled during the open field assay
was significantly less for WT;Mecp2flox and Mecp2 CKO
mice compared to Sim1-cre;WT littermates. No significant
differences were found between WT and Mecp2 CKO
mice.
(D) Mecp2 CKO mice spent a similar amount of time in
the lit side of the light-dark box compared to all littermate
controls.
(E) Partition test for social interaction revealed that both
WT;Mecp2flox (p < 0.05) and Mecp2 CKO (p < 0.01) mice
spent significantly more time at the partition compared
to their WT and Sim1-cre;WT littermates.
N = 15–17/genotype for (B–E).
(F) In the resident intruder assay (n = 8/genotype), Mecp2
CKO mice exhibited significantly more tail rattles and
attacks compared to all littermate controls.
The colors used to denote genotypes are consistent for all
graphs. *p < 0.05, **p < 0.01, NS = nonsignificant for all
panels. Error bars represent ± SEM.and 5F) was not altered in Mecp2 CKO mice. Quantitative re-
verse transcriptase PCR (QRT-PCR) using cDNA from hypothal-
amus confirmed thatMc4r, Pomc1, and AgrpmRNA levels were
not significantly different betweenMecp2 CKOmice and control
littermates (data not shown). In contrast,Npy expression was re-
duced in the ARC but greatly induced in the DMH ofMecp2CKO
mice (Figures 5G and 5H). Increased expression of Npy in the
DMH occurs in several hyperphagic models of reduced MC4R
signaling, including the agouti yellow mutant (Ay), Mc4r /
mice, and WT rats during lactation, suggesting that Npy in the
DMH may be involved in feeding regulation mediated by MC4R
signaling (Chen et al., 2004; Kesterson et al., 1997). The robust
expression of Npy in the DMH of Mecp2 CKO mice suggests
that, althoughMc4r, Pomc1, and Agrp RNA levels are all normal,
MC4R signaling may be disrupted in Mecp2 CKO mice.
The Expression of Two MC4R Downstream Targets
Is Decreased inMecp2 CKO Mice
We next sought to determine whether any downstream compo-
nents of the MC4R signaling pathway were altered in Mecp2
CKOmice. RNA in situ hybridization revealed that Bdnf, a neuro-
trophic factor important for weight regulation (Rios et al., 2001)and proposed to function as a downstream mediator of MC4R
signaling (Tsao et al., 2008; Xu et al., 2003), was significantly
decreased in the PVN of Mecp2 CKO mice compared to WT lit-
termates (Figures 6C and 6D). In contrast, Bdnf expression in
Mecp2 CKO mice was comparable to littermate controls in sev-
eral nuclei of the amygdala (Figures 6A and 6B) and in the ven-
tromedial nucleus of the hypothalamus (VMH) (Figures 6E and
6F). To quantify Bdnf expression, the in situ images from four
to seven mice per genotype were pseudocolored using the
Celldetekt protocol to determine the relative expression level
on a per cell basis (Carson et al., 2005), and, subsequently,
the total number of Bdnf-expressing cells was counted through-
out the PVN (Figure 6G) and the VMH (Figure 6H). We found
a 50% decrease (p < 0.05) in the number of cells that express
Bdnf in the PVN of Mecp2 CKO mice (Figure 6G). The fact
that Bdnf expression was altered only in areas of the brain
where there was strong Cre expression andMecp2 was deleted
(PVN) suggests that Bdnf levels are directly affected by the loss
of MeCP2.
In addition to BDNF, CRH has also been suggested as a down-
stream mediator of MC4R signaling (Lu et al., 2003). RNA in situ
hybridization revealed a significant decrease in Crh in the PVN ofNeuron 59, 947–958, September 25, 2008 ª2008 Elsevier Inc. 951
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SIM1 completely rescues the hyperphagia that occurs in Aymice
where MC4R signaling has been disrupted, suggesting that Sim1
also actsdownstreamof theMc4r inPVNneurons to regulate food
intake (Kublaoui et al., 2006). QRT-PCR demonstrated that, in
contrast to both Bdnf and Crh, the expression of Sim1 is not al-
tered in the Mecp2 CKO hypothalamus (Figure S3A). To confirm
that the expression of other genes that are highly expressed in
the PVN was similarly unaltered in Mecp2 CKO mice, we exam-
ined the expression of arginine vasopressin (Avp) and oxytocin
(Oxt) by QRT-PCR (Figures S3B and S3C). We found that both
Avp andOxt are expressed at WT levels in theMecp2CKO hypo-
Figure 3. Mecp2 CKO Mice Have Increased Body
Weight and Body Fat
(A) Mecp2 CKO and WT littermate at 40 weeks of age.
(B) Mecp2 CKO mice had significantly increased body
weight compared to all littermate controls beginning at
7 weeks of age (n = 15–17/genotype).
(C) Mecp2 CKO mice had significantly increased intra-
abdominal fat pad weight compared to all littermate con-
trols (n = 8/genotype).
(D) Mecp2 CKO mice had significantly increased percent
body fat compared to WT controls as determined by
DEXA scanning.
The colors used to denote genotypes are consistent for all
graphs. *p < 0.05, **p < 0.01, NS = nonsignificant. Error
bars represent ± SEM.
thalamus, suggesting that the cells in the PVN
retain at least some of their normal function.
DISCUSSION
In this study, we demonstrate that deletion of
Mecp2 in Sim1-expressing neurons results in
a subset of the phenotypes observed in RTT and related
MECP2 disorders. We found that Mecp2 CKO mice recapitu-
lated the increased body weight and abnormal stress response
that are observed inmice whereMecp2 is mutated in all neurons.
This result is interesting in light of the fact that patients with RTT
syndrome have also been found to exhibit an abnormal physio-
logical response to stress (Motil et al., 2006). Importantly, we
did not recapitulate all of the phenotypes typically seen upon de-
letion ofMecp2 from the entire brain, such asmotor coordination
abnormalities and learning and memory deficits, demonstrating
that the function of MeCP2 in Sim1-expressiong neurons is likely
not important for those behaviors. By removing Mecp2 fromFigure 4. Mecp2 CKO Mice Have Normal Activity
Levels and Basal Metabolic Rates but Display
Increased Food Intake and Serum Leptin Levels
(A) The 24 hr total movement values over 8 days. No
significant differences were identified after 4 days of
acclimation.
(B) Oxygen consumption values as measured by an indi-
rect open circuit calorimeter system revealed no signifi-
cant differences between genotypes.
(C) The 24 hr food intake values over 8 days. Mecp2 CKO
mice consume significantly more chow than all of their
control littermates.
N = 5–9/genotype for (A–C).
(D) Serum leptin measurement by ELISA at 6 weeks (n = 4/
genotype) and at 42 weeks (n = 6–7/genotype) in Mecp2
CKO mice and control littermates. Mecp2 CKO mice had
increased serum leptin levels compared to all littermate
controls at 42 weeks, but not at 6 weeks of age.
The colors used to denote genotypes are consistent for all
graphs. **p < 0.01, ***p < 0.001, NS = nonsignificant. Error
bars represent ± SEM.952 Neuron 59, 947–958, September 25, 2008 ª2008 Elsevier Inc.
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MeCP2 Plays a Critical Role in Sim1 NeuronsSim1-expressing neurons, we also uncovered a role for MeCP2
in the MC4R signaling pathway that regulates food intake and in
pathways important for aggression. Although aggression and
hyperphagia are not typically seen in patients with classic RTT,
patients with atypical RTT owing to favorable XCI or to hypomor-
phic MECP2 alleles do, indeed, manifest aggressive behavior
(P. Huppke, personal communication; H.Y.Z., unpublished
data), and some are overweight (Couvert et al., 2001; Kleefstra
Figure 5. RNA In Situ Hybridization Demonstrates that Mecp2 CKO
Mice Have Normal Expression ofMc4r, Pomc1, and Agrp but Altered
Npy Compared to WT Controls
(A) Mc4r expression in WT PVN.
(B) Mc4r expression in Mecp2 CKO PVN.
(C) Pomc1 expression in WT ARC.
(D) Pomc1 expression in Mecp2 CKO ARC.
(E) Agrp expression in WT ARC and (F) Mecp2 CKO ARC.
(G) Npy expression in WT DMH (gray arrow) and ARC (black arrow).
(H) Npy expression is greatly increased in DMH (gray arrow) but decreased in
the ARC (black arrow) of Mecp2 CKO mice compared to WT littermates.et al., 2002; Zappella et al., 2001). It is possible that these pheno-
types are not observed upon MeCP2 dysfunction in all neurons
due to secondary changes that maymask certain primary effects
of MeCP2 dysfunction. It is noteworthy that deletion of Mecp2
from other selected brain regions, such as the Purkinje cells of
the cerebellum or tyrosine hydroxylase neurons, does not result
in similar phenotypes (J.L.N. and H.Y.Z., unpublished data),
highlighting the specificity of the phenotypes observed in this
study and the important role of Mecp2 in the hypothalamus.
Mecp2 CKO mice displayed increased aggressive behavior
that was apparent strictly upon changes in social situations,
such as exposure to either an unfamiliar or intruder mouse.
The fact that aggression is not detected in the home cage but
Figure 6. RNA In Situ Hybridization Demonstrates that Mecp2 CKO
Mice Display Decreased Expression of Bdnf in the PVN but Normal
Expression throughout the Amygdala
Bdnf expression throughout the basolateral amygdala (BLA), basomedial
amygdala (BMA), and the medial amygdala (MeA) in (A) WT and (B) Mecp2
CKO mice. Bdnf expression in (C) WT and (D)Mecp2 CKO PVN. Bdnf expres-
sion in (E) WT VMH and (F)Mecp2 CKO VMH. The outlined area highlights the
VMH. Bdnf-expressing neurons were counted on sections throughout the (G)
PVN and (H) VMH.
Error bars represent ± SEM.Neuron 59, 947–958, September 25, 2008 ª2008 Elsevier Inc. 953
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MeCP2 Plays a Critical Role in Sim1 Neuronsis precipitated by the stress of unfamiliarity is interesting given
that patients with autism spectrum disorders typically manifest
aggression when stressed or frustrated. When interpreting the
resident intruder data, it is of note that the Mecp2 CKO mice
were heavier than their control littermates. The intruder mice
were slightly smaller than all of the mice that were tested, al-
though this difference in body weight was more pronounced in
the case of the Mecp2 CKO mice because the latter are much
larger than their control littermates. While it is possible that the
increased body weight of the Mecp2 CKO mice may have con-
tributed to the development of their increased aggression, the
fact that the aggressive behavior was detected only in response
to a smaller novel mouse and not in response to their smaller reg-
ular cage mates suggests that the increased body weight alone
is not likely responsible for the aggressive phenotype.
Stress undoubtedly represents an altered physiological state;
thus, the finding that Mecp2 CKO mice cannot easily adjust to
a new state adds to the growing evidence suggesting that
MeCP2 is important for the modulation of gene expression in re-
sponse to alterations in neuronal activity owing to new physio-
logic states (Chahrour and Zoghbi, 2007; Chen et al., 2003). For
example, MeCP2 is important for the neuronal activity-depen-
dent regulation of Bdnf (Zhou et al., 2006). Furthermore, genes
that are normally induced in response to stress, such as serum
glucocorticoid-inducible kinase 1 (Sgk1) and FK506-binding pro-
tein 5 (Fkbp5), are misregulated in the Mecp2 null brain (Nuber
et al., 2005). Although we do not yet understand the molecular
basis for the aggression phenotype seen in the Mecp2 CKO
mice, we have demonstrated that MeCP2’s function, specifically
in Sim1-expressing neurons, is critical to ensure proper social
behavior in response to novel and stressful social situations.
We also found thatMecp2CKOmice are obese based on their
significantly increased body weight, close to a 100% increase in
body fat content by 20 weeks of age, and an apparent resistance
to leptin. Mecp2 CKO mice display normal levels of activity and
basal metabolic rates, but they consumemore chow than control
littermates. Once again, deletion of Mecp2 in Sim1-expressing
neurons impairs the ability of the mouse to adapt to changing
physiology; in this case, Mecp2 CKO mice do not stop eating
once they have ingested a sufficient number of calories, demon-
strating that they are unable to properly respond to satiety
signals.
Hyperphagia and obesity are characteristic of mice that have
disruptedMC4R signaling. MC4Rs function by integrating an ag-
onist satiety signal from a-MSH (a cleavage product of POMC)
Figure 7. RNA In Situ Hybridization Demonstrates that Mecp2 CKO
Mice Display Decreased Expression of Crh in the PVN
Crh expression in representative sections of (A) WT and (B)Mecp2 CKO PVN.954 Neuron 59, 947–958, September 25, 2008 ª2008 Elsevier Inc.and an antagonist signal provided by AgRP (Oswal and Yeo,
2007). The essential role of MC4Rs in the control of food intake
is evident based on the hyperphagia and severe obesity seen
in Mc4r / mice (Huszar et al., 1997), mice that overexpress
theMC4R antagonist (Ay) (Kesterson et al., 1997), and in humans
with naturally occurring mutations in MC4R (Lubrano-Berthelier
et al., 2006). MC4Rs are densely expressed in the PVN, an
area that receives inputs from both POMC and AgRP/NPY neu-
rons, and their function, specifically in the PVN, is essential to
maintain proper control of food intake (Balthasar et al., 2005).
We demonstrate that Mecp2 CKO mice express normal levels
of Mc4r, Pomc1, and Agrp, but they have a small decrease in
Npy in the ARC and a profound induction of Npy in the DMH.
The finding that Npy is decreased in the ARC is not surprising
since NPY neurons in the ARC typically respond to increases
in leptin by downregulating the expression of Npy (Stephens
et al., 1995). Increased Npy expression in the DMH, however,
has been noted in a variety of rodent models that exhibit reduced
function of melanocortin pathways, including the agouti yellow
mice (Ay), tubbymice, diet-induced obese mice (DIO),Mc4r /
mice, and WT lactating rats (Chen et al., 2004; Guan et al.,
1998; Kesterson et al., 1997). Importantly, increased expression
of Npy in the DMH is not associated with all models of genetic
obesity since leptin-deficient ob/ob mice do not display detect-
able levels of Npy in the DMH (Kesterson et al., 1997). Thus, the
ectopic expression of Npy in the DMH serves as a marker of dis-
rupted MC4R signaling, which seems to be occurring in the
Mecp2 CKO mice.
Because our data point to a disruption of MC4R signaling in
the Mecp2 CKO mice despite normal expression of upstream
components of the pathway, we examined some of the down-
stream mediators of MC4R signaling in the PVN. Recent studies
have suggested that both CRH and BDNF function as down-
stream effectors in the MC4R signaling pathway (Lu et al.,
2003; Tsao et al., 2008; Xu et al., 2003). We found decreased ex-
pression of Crh in the PVN of theMecp2 CKOmice. This is inter-
esting becauseMC4R agonists increase the expression ofCrh in
the PVN (Lu et al., 2003), whereasMc4r/mice have low levels
of Crh in the PVN (see discussion in Lu et al., 2003), suggesting
that the decreased Crh observed in the Mecp2 CKO mice may
represent another marker of disrupted MC4R signaling.
We also found that Bdnf expression was decreased strictly in
the PVN of Mecp2 CKO mice. Studies in neuronal cultures sug-
gest that Bdnf is a direct target of MeCP2 and that MeCP2 func-
tions as a transcriptional repressor to inhibit Bdnf transcription
specifically from promoter III (Chen et al., 2003; Martinowich
et al., 2003). These data conflict, however, with recent in vivo ev-
idence demonstrating that BDNF levels are low rather than high
inMecp2 null mouse brain (Chang et al., 2006). Our data showing
that Bdnf is decreased in neurons lacking MeCP2 is consistent
with the in vivo data. Because low levels of Bdnf occur only in
the cells where Mecp2 has been deleted in the Mecp2 CKO
mice, it seems likely that the decreased expression is occurring
as a primary result of MeCP2 deficiency. Given recent data
showing that MeCP2 binds to the promoter region of many
actively expressed genes (Yasui et al., 2007), that MeCP2 can
function as both an activator and a repressor of gene expression
in the hypothalamus (Chahrour et al., 2008), that Bdnf is
Neuron
MeCP2 Plays a Critical Role in Sim1 Neuronssignificantly downregulated inMecp2 null mice, and that MeCP2
overexpression results in increased BDNF III transcript levels in
cultured rat neurons and in MECP2 transgenic mice (Chahrour
et al., 2008; Chang et al., 2006; Klein et al., 2007), we propose
that MeCP2 functions as an activator of Bdnf transcription.
Several studies have documented the importance of BDNF in
the VMH and DMH for feeding regulation (Tsao et al., 2008;
Unger et al., 2007; Xu et al., 2003). Ay obese mice that have dis-
rupted MC4R signaling have a 30%–40% decrease in Bdnf ex-
pression in the VMH, but no changes were observed in the
PVN, DMH, or lateral hypothalamus (LH) (Xu et al., 2003). Our
data suggest a disruption in MC4R signaling, although we see
decreasedBdnf expression in the PVN and not the VMH. This re-
sult is not surprising since we have only deletedMecp2 from the
PVN, not the VMH, and we believe that the misregulation of Bdnf
is occurring as a direct result of the absence of MeCP2. Future
studies should examine Bdnf expression in the VMH and the
PVN ofMc4r/mice to determine whether decreased expres-
sion occurs in one or both nuclei. Data supporting the fact that
BDNF is important specifically in the PVNhas come froma recent
study that demonstrated that BDNF administration into the PVN
was sufficient to significantly decrease food intake and body
weight in mice (Wang et al., 2007). MC4Rs are densely ex-
pressed in the PVN, and activation of these receptors leads to
an acute release of BDNF in the hypothalamus, which is neces-
sary for MC4R-induced effects on appetite (Nicholson et al.,
2007). If MeCP2 is important for the activation of Bdnf transcrip-
tion, then the required release of BDNF in response to MC4R
activation would likely be impaired, at least in the PVN of
Mecp2 CKO mice.
We have demonstrated that MeCP2 plays an important role in
the hypothalamus, an area of the brain where neurons are con-
stantly responding to a variety of physiological stimuli. Specifi-
cally, we have demonstrated that the loss of MeCP2 seems to
disrupt the typical homeostatic responses to food intake, novel
environment, and stress, consistent with a role for MeCP2 in
themodulation of neuronal responses to changing stimuli (Chah-
rour and Zoghbi, 2007; Chen et al., 2003; Zhou et al., 2006). It is
interesting that we found decreased expression of Bdnf in the
PVN of Mecp2 CKO mice since conditional deletion of Bdnf
from postmitotic neurons results in enhanced aggression and
obesity (Koizumi et al., 2006; Lyons et al., 1999; Rios et al.,
2001). Therefore, our data support a model where MeCP2 is
required for the proper expression of Bdnf in the PVN, and we
propose that misregulation of Bdnf expression may lead to dis-
rupted social behavior in the form of aggression and to hyper-
phagia and obesity, owing to disrupted MC4R signaling.
Importantly, by using a conditional knockout strategy, wewere
able to reproduce a subset of RTT orMecp2 null phenotypes and
uncover additional functions of MeCP2. The many phenotypes
that are seen in patients with RTT stem fromMeCP2 dysfunction
in neurons throughout the brain. Our study suggests that condi-
tional deletion of Mecp2 in different cell populations or different
regions of the brain will enable us to map the neuroanatomic
origins of the complex behaviors and phenotypes seen in RTT
and MECP2 disorders. Lastly, this study revealed that the
more restrictive we are in choosing the neurons in which to
delete Mecp2, the more we will learn about the function ofMeCP2 in specific neurons and the neurobiological basis of cer-
tain behaviors.
EXPERIMENTAL PROCEDURES
Animals
Mice were maintained on a 12 hr light, 12 hr dark cycle with regular mouse
chow and water ad libitum. Mecp2flox mice were a gift from Adrian Bird, and
Sim1-cre mice were from Brad Lowell and Joel Elmquist. All of the mice
used in these experiments were generated by crossing heterozygous female
Mecp2flox/+ mice that had been backcrossed to 129 Sv/Ev for seven genera-
tions to male Sim1-cre mice on a pure FVB background. F1 129/FVB male
littermates (64) representing all four possible genotypes were group-housed
immediately after weaning so that each cage contained onemouse of each ge-
notype. All research and animal care procedures were approved by the Baylor
College of Medicine Animal Care and Use Committee.
MeCP2 Immunostaining
Mice were anesthetized (avertin) and perfused with 10% formalin for 8 min.
Brains were dissected and postfixed in 10% formalin overnight at 4C. The
samples were cryoprotected in 30% sucrose/1 3 PBS, and 50 mm sections
were cut from hypothalamus blocks and suspended in 24-well tissue culture
plates containing 1 3 PBS. Sections were blocked in 2% normal goat sera
with 0.3% Triton X-100 for 1 hr at 4C, incubated for 48 hr in a 1:100 dilution
of anti-MeCP2 (Upstate cat. no. 07-013), and then incubated for 48 hr in
1:500 Cy3-labeled goat-anti-rabbit (Jackson ImmunoResearch Labs). 1:2000
TOTO-3 (Invitrogen cat. no. T3604) was added to the last wash. Sections
were mounted with ProLong Gold antifade mounting medium (Invitrogen cat.
no. P-36931). Images were collected from optical sections that were obtained
using a Zeiss 510 confocal microscope and processed using ImageJ (http://
rsb.info.nih.gov/ij/).
Corticosterone Measurement
Mice were left undisturbed for 12 hr and then retro-orbitally bled between
07:00 and 09:00 hr. Before the first bleed, half of the animals were restrained
in 50 ml conical tubes for 30 min (stress condition). The remaining animals
were kept in their home cages (basal condition). At 3 weeks later, the mice
were bled again, this time with the conditions reversed. Blood was collected
in prechilled tubes containing lithium heparin and centrifuged at 0.8 3 g for
10 min, and serum was collected and frozen at 80C until it was analyzed.
Serum corticosterone levels were measured using an enzyme-linked immuno-
sorbent assay (ELISA) (IDS Inc., Fountain Hills, AZ). The data were analyzed by
one-way ANOVA with Tukey’s post hoc analysis.
Behavioral Assays
Open Field Assay
The experiment was performed as previously described (Spencer et al., 2006)
with a few modifications. The open field apparatus consisted of a clear, open-
topped Plexiglas box (40 3 40 3 30 cm) with photo beams to record the
movement of the mouse within the box. Overhead lighting provided 200 lux
of illumination and a white noise generator (Lafayette Instruments, Lafayette,
IN) maintained background noise at 60 dB. Mice at 15 weeks of age were
placed in the center of the box, and their activity was quantified over a
30 min period. Data were collected by a computer-operated digiscan optical
animal activity system (Acuscan Electronics, Columbus, OH). Data were ana-
lyzed by one-way ANOVA with Tukey’s post hoc analysis.
Light-Dark Box
The assay was performed as described (Spencer et al., 2006) with a few mod-
ifications. The light-dark box consisted of a clear Plexiglas chamber (363 203
26 cm)with an open top separated from a covered black chamber (15.53 203
26 cm) by a black partition with a small opening. The open chamber was illu-
minated to 700 lux. Mice at 14 weeks of age were placed into the illuminated
side and allowed to explore freely for 10 min. Mice were scored for the number
and latency of entries and time spent in each compartment, using a hand-held
computer (Psion Workabout mx, Psion Teklogix) with the Observer program
(Noldus Information Technologies). An entry was scored when the mouseNeuron 59, 947–958, September 25, 2008 ª2008 Elsevier Inc. 955
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MeCP2 Plays a Critical Role in Sim1 Neuronsplaced all four feet into either the light or dark zone. White noise was present at
60 dB in the test chamber. Data were analyzed by two-way ANOVA for
a Mecp2flox allele 3 Sim1-cre allele interaction and by one-way ANOVA with
Tukey’s post hoc analysis.
Partition Test
This test was performed as previously described (Spencer et al., 2005) with
a few modifications. Test mice at 20 weeks of age were individually housed
in standard housing cages for 4 days. Each cage was separated into two com-
partments by a perforated barrier. On day 5 of individual housing, age- and
gender-matched C57/BL6 partner micewere placed into the compartment op-
posite the test mice. Paired mice were cohoused in the separate halves of the
partitioned cage for at least 18 hr. Following this period of induced familiarity,
the time that test mice displayed directed interest in their partner mice was re-
corded during three different paradigms: test subject versus familiar partner,
test subject versus unfamiliar partner, and repeated test subject versus familiar
partner. Each behavioral paradigm was assessed during three 5 min intervals
and was performed in sequential order. The presence or absence of aggres-
sive behavior (direct attacks through the partition holes and tail rattling) was
also scored during the three test intervals. Data were analyzed using a re-
peated-measures ANOVA (genotype 3 time) and Tukey’s post hoc analysis.
Resident Intruder
Mice at 42 weeks of age were individually housed for 2 weeks prior to the test
to establish dominance in their home cage. Each singly housed test male was
confronted with a lighter, group-housed WT opponent (C57BL/6) in its home
cage for 10 min. The occurrence of mounting, biting, tail rattling, and attacking
was recorded. To avoid injuries, the experiment was stopped if intense fighting
occurred. Data were analyzed by a nonparametric Kruskal-Wallis test.
Home Cage Behavioral Monitoring and Food Intake Measurements
Food and water intake measurements were performed similarly to what was
described inWade et al. (2008) with a fewmodifications. Micewere individually
housed for 8 days in cages (45 3 24 3 17 cm) with feeders and water bottles
mounted at one end. Intake of food and water were determined daily. The ca-
ges were placed on activity-monitoring platforms with two load beams at the
front of the platform and a central pivot that allowed estimation of the position
of the animal’s center of gravity (DiLog Instruments, Tallahassee, FL). Data
were collected from the activity platform into daily event files using two per-
sonal computers (DiLog Instruments, Tallahassee, FL). A movement event
was defined as the detection of a change in the animal’s center of gravity be-
yond a radius of 1 cm (calculated online from the animal’s body weight and the
forces on two load beams after filtering with a 500 ms moving average win-
dow). The movement event files recorded the onset of movement events sam-
pled every 20 ms as well as the distance moved in x and y. The amount of food
consumed was measured by weighing the chow placed in the cage each
morning and subtracting the amount of chow left after a 24 hr period. Mean
food intake and movement for the last 4 days of data collection was used
for group comparisons to allow 4 days of acclimation to the housing condi-
tions. Data were analyzed by one-way ANOVA with Tukey’s post hoc analysis.
Basal Metabolic Rate Determination
Indirect calorimetry was performed to determine oxygen consumption. Mice
were placed in a four-chamber indirect open circuit calorimeter system (Oxy-
max; Columbus Instruments, Columbus, OH) maintained at 22C. Food was
removed at 12:00 hr. The mice were placed in the calorimetry chamber at
13:00 hr and were removed from the system at 18:00 hr. Each chamber
(dimensions: 20 3 10 3 12 cm) received an airflow rate of 600 ml/min, and
samples were collected at 15 min intervals. The calorimetry chambers were
placed within photobeam activity monitors (San Diego Instruments, San
Diego, CA) in order to measure physical activity simultaneously. Estimates of
resting oxygen consumption or basal metabolic rate were made by averaging
VO2 measurements during periods when the mice broke ten beams or less.
Data were analyzed by one-way ANOVA with Tukey’s post hoc analysis.
Body Weight, Body Length, and Body Fat Measurements
Weight gain was measured each week beginning after weaning until 18 weeks
of age. Nose-to-anus distance was measured after lightly anesthetizing each
mouse in order to permit similar body extension. Intra-abdominal fat pads
were dissected and weighed after the mice were anesthetized with isofluorane956 Neuron 59, 947–958, September 25, 2008 ª2008 Elsevier Inc.and then cervically dislocated. A Lunar PIXImus Densitometer (GE Medical
Systems) was used to perform DEXA scans, and Lunar PIXImus 2.10 software
was used to analyze the results in order to estimate percent body fat. The av-
erage of two scans was used for each mouse. Before the scan, mice were
anesthetized using avertin at a dosage of 0.017–0.020 cc/g. Body weight
data were analyzed using repeated-measures ANOVA with Tukey’s post
hoc, body length and fat pad weights were analyzed by one-way ANOVA
with Tukey’s post hoc, and percent body fat was analyzed by Student’s t test.
Leptin Measurement
Blood was collected between 13:00 hr and 16:00 hr by retro-orbital bleed. Se-
rum leptin levels were measured using a commercially prepared mouse leptin
enzyme-linked immunoassay kit (American Laboratory Products Company,
Windham, NH; cat. no. 22-LEP-E06, lot no. 090107). Data were analyzed by
one-way ANOVA with Tukey’s post hoc.
Nonradioactive In Situ Hybridization (ISH)
Coronal sections from two to four mice of each genotype were analyzed for
each gene. Tissue preparation and automated ISH were performed as previ-
ously described (Carson et al., 2002; Visel et al., 2004; Yaylaoglu et al.,
2005) and as described online at http://www.genepaint.org/RNA.htm. Mc4r,
Pomc1, Agrp, Npy, Bdnf, and Crh antisense probes were generated from
cDNA clones. The cDNA templates were amplified by PCR and used for
in vitro transcription of digoxygenin-labeled riboprobe. We performed quanti-
tative analysis of the Bdnf ISH signal on sections spanning the entire PVN and
VMH using the Celldetekt protocol to determine cellular gene expression
strengths (Carson et al., 2005). Data were analyzed using a two-tailed
Student’s t test.
SUPPLEMENTAL DATA
The Supplemental Data include Supplemental Experimental Procedures, three
figures, and twomovies and can be foundwith this article online at http://www.
neuron.org/cgi/content/full/59/6/947/DC1/.
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